サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1540805

免疫診断市場レポート：製品、技術、用途、エンドユーザー、地域別、2024～2032年

Immunodiagnostics Market Report by Product, Technology, Application, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 146 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.32円
免疫診断市場レポート：製品、技術、用途、エンドユーザー、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の免疫診断市場規模は2023年に188億米ドルに達しました。今後、IMARC Groupは、2024～2032年にかけて6.7%の成長率（CAGR）を示し、2032年までに343億米ドルに達すると予測しています。

市場規模 年平均成長率（CAGR）グラフ | 免疫診断市場レポート：製品、技術、用途、エンドユーザー、地域別、2024～2032年

免疫診断とは、感染症や慢性疾患の検出に抗原抗体反応を用いる体外診断技術のことです。疾患の進行を特定するための標的範囲の拡大を助ける抗体の同定に、放射線、蛍光、発色酵素、プローブを使用します。免疫診断は、酵素結合免疫吸着測定法、化学発光法、ラジオイムノアッセイ法、迅速試験のための様々な試薬、機器、ソフトウェアベースのソリューションも使用します。これらのソリューションは、がんや自己免疫疾患、呼吸器疾患、内分泌疾患、腫瘍疾患などの病気の診断や、法医学心理学、環境・食品分析などに広く利用されています。その結果、免疫診断は、病院、臨床試験室、研究機関、学術機関など幅広いセグメントで応用されています。

免疫診断市場動向：

大衆の間で慢性疾患や感染症が増加していることは、市場成長を促進する主要要因の1つです。さらに、このような病気にかかりやすい高齢者人口の増加が、市場の成長を後押ししています。また、B型肝炎、糖尿病、がんなどの病気の治療法に関する消費者の意識も高まっており、免疫診断キット、アッセイ、分析装置の需要にプラスの影響を与えています。さらに、次世代免疫診断プラットフォームの開発など、様々な技術的進歩が市場の成長を促進すると予想されています。これらの先進的なポイントオブケア試験（POCT）システムは、敗血症、急性心筋梗塞、死亡率の高いその他の医療疾患に対する診断設備を強化します。その他、新興経済諸国を中心とした医療インフラの改善とともに、大衆の間で個別化された医薬品への要求が高まっていることなどが、市場の成長を促進すると予測されます。

本レポートで扱う主要質問

  • 免疫診断市場の世界市場規模は？
  • 2024～2032年にかけての世界の免疫診断市場の予想成長率は？
  • 世界の免疫診断市場を牽引する主要因は何か？
  • 世界の免疫診断市場に対するCOVID-19の影響は？
  • 世界の免疫診断市場の用途別内訳は？
  • 世界の免疫診断市場のエンドユーザー別内訳は？
  • 免疫診断市場の世界における主要地域は？
  • 世界の免疫診断市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の免疫診断市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 試薬
  • 機器
  • ソフトウェアとサービス

第7章 市場内訳：技術別

  • 酵素免疫測定法
  • 化学発光免疫測定法
  • 蛍光免疫測定
  • 放射免疫測定
  • 迅速試験
  • その他

第8章 市場内訳：用途別

  • 感染症
  • 腫瘍学と内分泌学
  • 肝炎とレトロウイルス
  • 骨とミネラル
  • 自己免疫
  • 心臓バイオマーカー
  • その他

第9章 市場内訳：エンドユーザー別

  • 病院
  • 臨床試験室
  • 学術研究センター
  • 製薬・バイオテクノロジー産業
  • その他

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Arkray Inc.
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • DiaSorin S.p.A.
    • F. Hoffmann-La Roche AG
    • Immunodiagnostic Systems Holdings PLC
    • Johnson & Johnson
    • Siemens AG
    • Sysmex Corporation
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Immunodiagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Immunodiagnostics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Immunodiagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Immunodiagnostics Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Immunodiagnostics Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Immunodiagnostics Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Immunodiagnostics Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Immunodiagnostics Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Immunodiagnostics (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Immunodiagnostics (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Immunodiagnostics (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Immunodiagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Immunodiagnostics (Software and Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Immunodiagnostics (Software and Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Immunodiagnostics (Enzyme-Linked Immunosorbent Assay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Immunodiagnostics (Enzyme-Linked Immunosorbent Assay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Immunodiagnostics (Chemiluminescence Immunoassay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Immunodiagnostics (Chemiluminescence Immunoassay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Immunodiagnostics (Fluorescent Immunoassay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Immunodiagnostics (Fluorescent Immunoassay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Immunodiagnostics (Radioimmunoassay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Immunodiagnostics (Radioimmunoassay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Immunodiagnostics (Rapid Test) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Immunodiagnostics (Rapid Test) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Immunodiagnostics (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Immunodiagnostics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Immunodiagnostics (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Immunodiagnostics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Immunodiagnostics (Oncology and Endocrinology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Immunodiagnostics (Oncology and Endocrinology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Immunodiagnostics (Hepatitis and Retrovirus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Immunodiagnostics (Hepatitis and Retrovirus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Immunodiagnostics (Bone and Mineral) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Immunodiagnostics (Bone and Mineral) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Immunodiagnostics (Autoimmunity) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Immunodiagnostics (Autoimmunity) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Immunodiagnostics (Cardiac Biomarker) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Immunodiagnostics (Cardiac Biomarker) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Immunodiagnostics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Immunodiagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Global: Immunodiagnostics (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Global: Immunodiagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Global: Immunodiagnostics (Clinical Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Global: Immunodiagnostics (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Global: Immunodiagnostics (Academic and Research Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Global: Immunodiagnostics (Academic and Research Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Global: Immunodiagnostics (Pharmaceutical and Biotechnology Industry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Global: Immunodiagnostics (Pharmaceutical and Biotechnology Industry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Global: Immunodiagnostics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Global: Immunodiagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: North America: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: North America: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: United States: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: United States: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Canada: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Canada: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Asia-Pacific: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Asia-Pacific: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: China: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: China: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Japan: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Japan: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: India: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: India: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: South Korea: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: South Korea: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Australia: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Australia: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Indonesia: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Indonesia: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Others: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Others: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Europe: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Europe: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Germany: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Germany: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: France: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: France: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: United Kingdom: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: United Kingdom: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Italy: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Italy: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Spain: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Spain: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Russia: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Russia: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Others: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Others: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Latin America: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 90: Latin America: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 91: Brazil: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 92: Brazil: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 93: Mexico: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 94: Mexico: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Others: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 96: Others: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 97: Middle East and Africa: Immunodiagnostics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 98: Middle East and Africa: Immunodiagnostics Market: Breakup by Country (in %), 2023
  • Figure 99: Middle East and Africa: Immunodiagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 100: Global: Immunodiagnostics Industry: SWOT Analysis
  • Figure 101: Global: Immunodiagnostics Industry: Value Chain Analysis
  • Figure 102: Global: Immunodiagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunodiagnostics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Immunodiagnostics Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Immunodiagnostics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 4: Global: Immunodiagnostics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Immunodiagnostics Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Immunodiagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Immunodiagnostics Market: Competitive Structure
  • Table 8: Global: Immunodiagnostics Market: Key Players
目次
Product Code: SR112024A4249

The global immunodiagnostics market size reached US$ 18.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 34.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032.

Immunodiagnostics refers to an in-vitro diagnostic technology that uses antigen-antibody reaction for the detection of infectious and chronic diseases. It involves the use of radiological, fluorescent or color-forming enzymes and probes for the identification of antibodies that aid in enhancing the targeting range to identify disease progression. Immunodiagnostics also uses various reagents, instruments and software-based solutions for enzyme-linked immunosorbent assay, chemiluminescence, radioimmunoassay and rapid testing. These solutions are widely used for diagnosing diseases, such as cancer and autoimmune, respiratory, endocrine and oncological disorders, along with forensic psychology and environmental and food analysis. As a result, immunodiagnostics finds extensive applications across hospitals, clinical laboratories and research and academic institutes.

Immunodiagnostics Market Trends:

The increasing prevalence of chronic medical ailments and infections among the masses is one of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the growth of the market. There is also an escalating awareness among the consumers regarding the available treatment alternatives for ailments, such as hepatitis B, diabetes and cancer, which is positively impacting the demand for immunodiagnostics kits, assays and analyzers. Additionally, various technological advancements, such as the development of next-generation immunodiagnostics platforms, are anticipated to drive the market toward growth. These advanced point-of-care testing (POCT) systems offer enhanced diagnostic facilities for sepsis, acute cardiac infractions and other medical disorders with higher mortality rates. Other factors, including the increasing requirement for personalized medicines among the masses, along with extensive improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global immunodiagnostics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, technology, application and end user.

Breakup by Product:

Reagents

Instruments

Software and Services

Breakup by Technology:

Enzyme-Linked Immunosorbent Assay

Chemiluminescence Immunoassay

Fluorescent Immunoassay

Radioimmunoassay

Rapid Test

Others

Breakup by Application:

Infectious Diseases

Oncology and Endocrinology

Hepatitis and Retrovirus

Bone and Mineral

Autoimmunity

Cardiac Biomarker

Others

Breakup by End User:

Hospitals

Clinical Laboratories

Academic and Research Centers

Pharmaceutical and Biotechnology Industry

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arkray Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche AG, Immunodiagnostic Systems Holdings PLC, Johnson & Johnson, Siemens AG, Sysmex Corporation and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. How big is the global immunodiagnostics market?
  • 2. What is the expected growth rate of the global immunodiagnostics market during 2024-2032?
  • 3. What are the key factors driving the global immunodiagnostics market?
  • 4. What has been the impact of COVID-19 on the global immunodiagnostics market?
  • 5. What is the breakup of the global immunodiagnostics market based on the application?
  • 6. What is the breakup of the global immunodiagnostics market based on the end user?
  • 7. What are the key regions in the global immunodiagnostics market?
  • 8. Who are the key players/companies in the global immunodiagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunodiagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Enzyme-Linked Immunosorbent Assay
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Chemiluminescence Immunoassay
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Fluorescent Immunoassay
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Radioimmunoassay
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Rapid Test
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Diseases
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oncology and Endocrinology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Hepatitis and Retrovirus
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Bone and Mineral
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Autoimmunity
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Cardiac Biomarker
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinical Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic and Research Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Pharmaceutical and Biotechnology Industry
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Arkray Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 bioMerieux SA
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Bio-Rad Laboratories Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 DiaSorin S.p.A.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 F. Hoffmann-La Roche AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Immunodiagnostic Systems Holdings PLC
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Johnson & Johnson
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Siemens AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Sysmex Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis